Nexalin Technology is a medical device company that designs and develops neurostimulation products to help combat the ongoing global mental health epidemic. Co. has developed a medical device, referred to as Generation 1, that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Co. has designed and developed new waveform technology to be emitted at 15 milliamps - referred to as Generation 2 which can penetrate deeper into the brain and stimulate associated structures of mental illness. Generation 2 is being tested in pilot trials, for anxiety, insomnia, and depression in the United States. We show 8 historical shares outstanding datapoints in our NXL shares outstanding history coverage, used to compute NXL market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing NXL market cap history over the course of time is important for investors
interested in comparing NXL's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of NXL versus a peer is one thing; comparing
NXL market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like NXL can fluctuate over the course of history.
With this page we aim to empower investors researching NXL by allowing them to research the NXL market cap history. |
Free NXL Email Alerts:
Video: The Importance of Market Cap
